Literature DB >> 2779234

Temporal actions of 16 alpha-hydroxyestrone in the rat: comparisons of lordosis dynamics with other estrogen metabolites and between sexes.

R H Lustig1, C V Mobbs, D W Pfaff, J Fishman.   

Abstract

16 alpha-Hydroxyesterone (16OHE1), a metabolite of estradiol (E2) and precursor of estriol (E3), binds to the estrogen receptor (ER) with low affinity (3% of E2), but is estrogenic in both in vitro and in vivo systems. This metabolite is able to bind in a non-dissociable manner to the ER. We examined these properties in vivo by assessing the temporal dynamics of estrogen metabolite action in the rat brain, using lordosis score (LS) to manual stimulation as a serial bioassay of estrogen effect. Male and female castrate Fisher rats were implanted with osmotic minipumps containing either vehicle, E2, 16OHE1, or E3. 16OHE1-induced LS was delayed in onset in both sexes relative to E2 and E3. Male LS reached a similar plateau for all metabolites, whereas female LS reached an initial LS plateau similar in amplitude to the male plateau. Over the next several days, female LS increased to reach a secondary plateau of higher amplitude, which persisted until pump removal. Upon pump removal, E2- and E3-stimulated LS fell to baseline quickly in both sexes, whereas 16OHE1-stimulated LS in males demonstrated a prolongation of maximal LS for 6 days following pump removal. These results suggest that 16OHE1 is estrogenic in the brains of both sexes. The delay of onset of LS with 16OHE1 is consistent with its poor ER affinity. Females were able to augment LS with prolonged exposure to all metabolites, while males could not. The ability of 16OHE1 to maintain maximal LS in the male long after its withdrawal is consistent with its ability to bind non-dissociably to the ER and promote prolonged estrogenic activation. However, females do not exhibit this response, suggesting a sex specificity in the dynamics of ligand-receptor action in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779234     DOI: 10.1016/0022-4731(89)90332-4

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  8 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

2.  Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension.

Authors:  Joshua P Fessel; Xinping Chen; Andrea Frump; Santhi Gladson; Tom Blackwell; Christie Kang; Jennifer Johnson; James E Loyd; Anna Hemnes; Eric Austin; James West
Journal:  Pulm Circ       Date:  2013-12-02       Impact factor: 3.017

Review 3.  Circulating sex steroids and breast cancer risk in premenopausal women.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  Horm Cancer       Date:  2010-02-09       Impact factor: 3.869

4.  Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Renée T Fortner; Susan E Hankinson; Catherine Schairer; Xia Xu; Regina G Ziegler; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-27       Impact factor: 4.254

5.  Is Estrogen a Missing Culprit in Thyroid Eye Disease? Sex Steroid Hormone Homeostasis Is Key to Other Fibrogenic Autoimmune Diseases - Why Not This One?

Authors:  Amy M FitzPatrick
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

6.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

7.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

8.  Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.

Authors:  H L Bradlow; D L Davis; G Lin; D Sepkovic; R Tiwari
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.